Lilly Gains Rights To Applied NeuroSolutions' Alzheimer's Research
This article was originally published in The Pink Sheet Daily
Executive Summary
Research includes expertise in the neuropathology of Alzheimer's as it relates to formation of neurofibrillary tangles.
You may also be interested in...
Genentech To Acquire AC Immune’s Beta-Amyloid Antibodies For Alzheimer’s Research
The biotech will pay more than $300 million for preclinical conformation-specific antibodies against beta-amyloid.
Genentech To Acquire AC Immune’s Beta-Amyloid Antibodies For Alzheimer’s Research
The biotech will pay more than $300 million for preclinical conformation-specific antibodies against beta-amyloid.
Elan Moving Alzheimer’s Candidate To Phase II Under Pact With Transition Therapeutics
Initial terms of the partnership include an unusual 70/30 split on development costs and eventual profits.